Relapsing-remitting Multiple Sclerosis Top Journals|omicsgroup|Journal Of Multiple Sclerosis

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Recommended Webinars & Conferences

Annual Summit on Neurological Disorders & Stroke

Webinar, Webinar

Relapsing-remitting Multiple Sclerosis Top Journals

Multiple sclerosis (MS) is defined as a probable autoimmune disease that severely affects the central nervous system (CNS), resulting in several pathologies that may be a result of different disease-causing mechanisms. Relapsing-Remitting Multiple Sclerosis is a common form of multiple sclerosis characterised by clear exacerbations due to inflammation. The disease is characterised by various symptoms such as bowel dysfunction, numbness, spasticity, balance issues, vertigo and pain. The common oral drugs being used for the treatment involves Gilenya, Aubagio, and Tecfidera. The top journals are peer reviewed scholarly journals. These provide high quality, meticulously reviewed and rapid publication, to cater the insistent need of scientific community. These journals are indexed with all their citations noted. The top open access journals are indexed in MEDLINE, PUBMED, SCOPUS, COPERNICUS, CAS, EBSCO and ISI.
  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger

Last date updated on April, 2021